Study of Clinical, Biological Characteristics and Quality of Life of Patients With Hereditary or Acquired Non Drug-induced Bradykinin-mediated Angioedema, Monitored in Besançon's Partner Site Reference Center for Studies of Kinin-mediated Angioedema (CREAK)

This study aims to describe quality of life in hereditary or acquired non drug-related bradykinin-mediated angioedema patients, using validated questionnaires

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Angioedema Cardiovascular Diseases Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Skin Diseases Skin Diseases, Vascular Skin and Connective Tissue Diseases Urticaria Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU Besançon

Besançon, 25000, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Clinically documented angioedema due to C1 inhibitor deficiency, hereditary (type I et II) or acquired
Clinically documented angioedema with normal C1 inhibitor activity (hereditary type III)

Exclusion criteria

Acquired angioedema with normal C1 inhibitor activity (former "drug-induced")
Minor subjects
Vulnerable subjects (under guardianship/curatorship/tutorship)
Pregnant women

Treatment and study plan

Quality of life

Other

Dermatology Life Quality Index, Angioedema Quality of Life Questionnaire, Angioedema Activity Score

Primary outcomes

Dermatology Life Quality Index (DLQI)

Time frame: 6 months

Description of Quality of Life (QoL) using DLQI
Angioedema Quality of Life (AE-QoL) Questionnaire

Time frame: 6 months

Description of QoL using AE-QOL questionnnaire

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Besancon

Other

Registry information

Acronym: QUALANGIO

Important dates

Study start: 2016
Primary completion: 2016
Study completion: 2016
First posted: Aug 7, 2017
Registry last updated: Apr 17, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed